Cancer
- BPR5K230/ Small Molecule AXL and MERTK Dual Kinase Inhibitor as Anticancer and Immunomodulatory Agent
- Abstract：Click here
- PowerPoint：Click here
- DBPR117/ A Monoclonal Antibody Targeting RSPO3/Wnt Signaling – Mediated Tumorigenesis
- Abstract：Click here
- PowerPoint：Click here
- DBPR728/ A Kinase Inhibitor Targeting MYC Driven Cancers- A precision medicine strategy for cancers
- Abstract：Click here
- PowerPoint：Click here
- DBPR807/ A CXCR4-Targeted Antagonist- Therapeutic Application of CXCR4 Antagonist DBPR807 Combined with Sorafenib in HCC
- Abstract：Click here
- PowerPoint：Click here
- DBPR22998/ A Potent QPCTL (IsoQC) Inhibitor Targeting CD47-SIRPα Axis for Cancer Immunotherapy
- Abstract：Click here
- PowerPoint：Click here
- NTSR1Ab/A novel antibody-drug conjugate (ADC)
targeting cancers expressing neurotensin receptor 1 (NTSR1)
- Abstract：Click here
- PowerPoint：Click here
CNS
- Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
- Abstract：Click here
- PowerPoint：Click here
- BPR1M492/ A MOR/NOP Dual Agonist as a Safe Pain Killer- Novel and Fast Acting Opioid Analgesic
- Abstract：Click here
- PowerPoint：Click here
- DBPR116/ An Antagonist-to-Agonist Allosteric Modulator- Pain Relief Agent with Limited Side Effects of Opioids
- Abstract：Click here
- PowerPoint：Click here
- Cutting Alzheimer’s Risk by 45%: Explore Our Innovative Pharmaceutical Combination Therapy
- Abstract：Click here
- PowerPoint：Click here
Vaccines
- A broad-spectrum pneumococcal vaccine
- Abstract：Click here
- PowerPoint：Click here
- FLIPr-Mediated Antigen Targeting to Dendritic Cells
- Abstract：Click here
- PowerPoint：Click here
Platform
- Novel Therapeutic Inducible Exosome (iExo) Platform for Regenerative Medicine
- Abstract：Click here
- PowerPoint：Click here
